Oxytrol For Women Patch
Product Images NDC 0023-9637

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oxytrol For Women (NDC 0023-9637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panelndc 0023-9637-04oxytrolfor Women4 Patches(transdermal Systems)16-day Supply (Oxytrol For Women 01)

Oxytrol for Women 3.9 mg/d transdermal patch packaging label. The label shows the product name and strength, indicating it is an overactive bladder treatment for women. The package contains 4 patches, covering a 16-day supply (1 patch treats 4 days/4 nights). Labeler Allergan, Inc. is displayed. Drug facts and usage instructions are visible on side panels.*

FDA Label Image

Oxytrol For Women 02

Packaging label for Oxytrol for Women 3.9 mg/d transdermal patch containing oxybutynin, manufactured by Allergan, Inc. The label indicates 8 patches per package, providing a 32-day supply, designed to treat overactive bladder symptoms. The label features branding, directions, drug facts, warnings, and barcode information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.